ST. ANNA KINDERKREBSFORSCHUNG GMBH
- Country
- Austria
- Type
- Beneficiary
- Grants received
- 19
Funding record
- 19 grants on record
- €9,486,636.37 awarded in total
- 2016–2024 years covered
This total adds up only the grants our sources publish. It is not the total funding this organisation has received.
Programmes
11 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations funded alongside this one on two or more projects. Sharing a single project does not count. Some projects have as many as 195 participants, and appearing on the same list once is not a working relationship.
- ST ANNA KINDERKREBSFORSCHUNG VEREIN
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN
- PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV
- STICHTING AMSTERDAM UMC
- OSPEDALE PEDIATRICO BAMBINO GESU
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
- EBERHARD KARLS UNIVERSITAET TUEBINGEN
- FAKULTNI NEMOCNICE V MOTOLE
Calls from this organisation
No published calls from this organisation.
Grants received
- EUROPEAN RARE DISEASES RESEARCH ALLIANCE
- Building models of fusion-driven sarcomas via cell fate engineering
- A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis
- Developmentally programmed pediatric sarcomas: a versatile platform for drug discovery and molecular precision medicine
- International Study for Treatment of Childhood Relapsed ALL 2020
- From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network
- High resolution dissection of non-coding determinants of disease
- Functional Interrogation of Non-coding DNA Sequences in leukemia development and drug resistance
- European Rare dIsease research Coordination and support Action
- PanCare studies of the scale-up and implementation of the digital Survivorship Passport to improve people-centred care for childhood cancer survivors
- Twinning in Research and Education to improve survival in Childhood Solid Tumours in Lithuania
- Validation of Actionable Genomic ABerrations in a paediatric Oncology Network for Doctorate students
- Integrated and standardized NGS workflows for Personalised therapy
- Charting key molecules and mechanisms of human immune Dysregulation
- European Joint Programme on Rare Diseases
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
We collected this from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.